Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.184 EUR 0.82% Market Closed
Market Cap: 8.2m EUR

Intrinsic Value

The intrinsic value of one CYAD stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.184 EUR, Celyad Oncology SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYAD Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Celyad Oncology SA

Intrinsic Value History
Dive into the past to invest in the future

CYAD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CYAD usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CYAD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CYAD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Celyad Oncology SA.

Explain Valuation
Compare CYAD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CYAD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Celyad Oncology SA

Current Assets 2.5m
Cash & Short-Term Investments 790k
Receivables 760k
Other Current Assets 910k
Non-Current Assets 3.2m
PP&E 1.3m
Intangibles 360k
Other Non-Current Assets 1.5m
Current Liabilities 3.7m
Accounts Payable 920k
Accrued Liabilities 390k
Other Current Liabilities 2.4m
Non-Current Liabilities 5.1m
Long-Term Debt 750k
Other Non-Current Liabilities 4.3m
Efficiency

Free Cash Flow Analysis
Celyad Oncology SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Celyad Oncology SA

Revenue
186k EUR
Cost of Revenue
-11k EUR
Gross Profit
175k EUR
Operating Expenses
-6.6m EUR
Operating Income
-6.4m EUR
Other Expenses
-30k EUR
Net Income
-6.5m EUR
Fundamental Scores

CYAD Profitability Score
Profitability Due Diligence

Celyad Oncology SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Celyad Oncology SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CYAD Solvency Score
Solvency Due Diligence

Celyad Oncology SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Celyad Oncology SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYAD Price Targets Summary
Celyad Oncology SA

There are no price targets for CYAD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Celyad Oncology SA
does not pay dividends
Shareholder Yield

Current shareholder yield for CYAD is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CYAD stock?

The intrinsic value of one CYAD stock under the Base Case scenario is hidden EUR.

Is CYAD stock undervalued or overvalued?

Compared to the current market price of 0.184 EUR, Celyad Oncology SA is hidden .

Back to Top